Vitality Watch

⚠ Evidence note: Mechanistic aging biology translates to human interventions slowly and unreliably; model-organism lifespan gains have repeatedly failed to transfer.

Mentioned 1× · first seen 20-sep-2026 · last seen 20-sep-2026

Hepatic ACAT3 in Cholesterol–Bile Acid–Microbiota Signaling

Current understanding

ACAT3 (acyl-CoA:cholesterol acyltransferase 3) is a liver-enriched cholesterol-esterifying enzyme proposed as an upstream node coupling hepatic cholesterol handling to bile-acid output, gut microbiota composition, and systemic energy homeostasis, based on a single male-mouse genetic characterization [animal-model]. Hepatic ACAT3 expression is reported to fall with obesity, diabetes, and aging, suggesting it as a candidate age-linked lesion in the liver arm of the gut–liver–metabolism axis, though evidence is currently confined to male mice with no human translation data [animal-model].

Evidence log

Open questions

Related

Contributing findings

pubmed preclinical
ACAT3 controls hepatic cholesterol metabolism and modulates systemic energy homeostasis of male mice.
08-jun-2026 novelty 3 per-area 3 introduces

build build 880 · 2bcef25 · 2026-11-18